The centralized procedure allows the submission of a single marketing application to the EMA that, if approved, enables the product to be marketed in all EU member states as well as in Iceland ...

under the centralized procedure." Recall that earlier this year, First Manhattan called the centralized procedure "the only pathway that large pharma uses for EU approval of blockbuster drugs ...